Boxer Capital Management, LLC — SEC Form 4 filings

SEC reporting owner CIK 2018299. 4 Form 4 filings on record with FilingPulse; latest filed 2024-11-07.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-10-22 to 2024-11-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tango Therapeutics, Inc. (TNGX)34 legs · 4,588,000 sh · $20,121,160
Tyra Biosciences, Inc. (TYRA)12

Form 4 filings — Boxer Capital Management, LLC

FiledFormIssuerReported transactionsSource
2024-11-074Tango Therapeutics, Inc. (TNGX)
jointly with Davis Aaron I.
Sale (S): 3,080,000 @ $3.14EDGAR
2024-10-284Tango Therapeutics, Inc. (TNGX)
jointly with Davis Aaron I.
Sale (S): 633,000 @ $6.87EDGAR
2024-10-234Tango Therapeutics, Inc. (TNGX)
jointly with Davis Aaron I.
Sale (S): 625,000 @ $7.05 · Sale (S): 250,000 @ $6.78EDGAR
2024-10-224Tyra Biosciences, Inc. (TYRA)Disposition to issuer (D): 2,000,000 · Grant/award (A): 2,000,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2018299 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →